U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06886620) titled 'Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal(R) in Patients With Intermittent Claudication' on March 13.
Brief Summary: The study is designed to compare the efficacy and safety of once daily PMR treatment with twice daily Pletaal(R) treatment in patients with intermittent claudication caused by peripheral arterial disease and are currently treated with cilostazol of any strength and any dosing frequency.
Study Start Date: March 14, 2016
Study Type: INTERVENTIONAL
Condition:
Intermittent Claudication
Intervention:
DRUG: Cilostazol 200 mg
Provided as 1# placebo tablet in the morning and...